Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Total Debt/Equity

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Total Debt/Equity(x) 0.020.030.04--

What is the latest Total Debt/Equity ratio of GLAND PHARMA ?

The latest Total Debt/Equity ratio of GLAND PHARMA is 0.02 based on Mar2026 Consolidated results.
Year Total Debt/Equity
Mar20260.02
Mar20250.03
Mar20240.04
Mar2023-
Mar2022-

How is Total Debt/Equity of GLAND PHARMA Trending?

Years Total Debt/Equity % Change
Mar2026 0.02
-33.33
Mar2025 0.03
-25.00
Mar2024 0.04
0
Mar2023 0
0
Mar2022 0 -

Other Financial Ratios of GLAND PHARMA


Compare Total Debt/Equity ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,224.6 Cr -1.7% -1.5% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.7%

-1.5%

57.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses